STEM CELL TRANSPLANTATION FOR PEOPLE WITH RELAPSING REMITTING MULTIPLE SCLEROSIS

That this House welcomes research from a recent clinical study which has shown that the transplantation of bone marrow stem cells may stop the progression of disability for people with relapsing remitting multiple sclerosis (MS) and even reverse the damage that has already been done; further welcomes the fact that stem cells are showing more and more potential in the treatment of MS as well as other neurological conditions such as stroke and spinal cord injury; and believes that the challenge now faced is in proving their effectiveness in trials involving large numbers of people.